About Us
Our Story
Leadership
Board of Directors
Our Science
Overview
Platform and Programs
Manufacturing
Our Pipeline
Investors & Media
Company Overview
Press Releases
Events and Presentations
Publications
FAQs
Careers
Contact Us
Events and Presentations
Upcoming Events
Past Events
July 12, 2022
CytoImmune CEO Dr. Christina Coughlin to Participate in Cell Therapy Panel at William Blair Biotech Focus Conference
June 29, 2022
CytoImmune CEO Dr. Christina Coughlin to Participate on CAR NK Panel During Stifel Cell Tx Event
June 28, 2022
CytoImmune CEO Dr. Christina Coughlin and Dr. Michael Caligiuri, co-founder and CSO, to Participate at Truist Securities Cell Therapy Symposium
May 4, 2022
CytoImmune CEO Dr. Christina Coughlin to Participate in “The Cell Therapy Landscape | CAR-T to Stem Cells” at the World Medical Innovation Forum
April 25, 2022
Chardan Annual Genetic Medicines & Cell Therapy Manufacturing Summit (fireside chat) at 9:00 a.m. ET.
April 14, 2022
Needham 21st Annual Virtual Healthcare Conference’s “NK Therapeutics Panel” at 11:45 a.m. ET
April 11, 2022
CytoImmune will present at the Locust Walk Stem Cell Tx Conference in Partnership with Harvard Stem Cell Institute
February 9, 2022
CytoImmune Therapeutics to Participate in the 2022 BIO CEO & Investor Conference and the SVB Leerink Global Healthcare Conference
November 9, 2021
CytoImmune will participate in the Stifel 2021 Virtual Healthcare Conference
September 5, 2021
CytoImmune Therapeutics | Wells Fargo Healthcare Conference
July 16, 2021
CytoImmune Therapeutics, Inc. CMO Michael Caligiuiri, MD to Present at a KOL Webinar on Human Natural Killer (NK) Cell Immunotherapy
July 16, 2021
CytoImmune Therapeutics, Inc. President William Rosellini to Present at Upcoming Conferences
Load more
Press Releases
Publications